<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">GAN</journal-id>
<journal-id journal-id-type="hwp">spgan</journal-id>
<journal-title>Genes &amp; Cancer</journal-title>
<issn pub-type="ppub">1947-6019</issn>
<issn pub-type="epub">1947-6027</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1947601913481355</article-id>
<article-id pub-id-type="publisher-id">10.1177_1947601913481355</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Monographs</subject>
<subj-group subj-group-type="heading">
<subject>Cell Cycle Progression Through G1 and the G1/S transition</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Bridges between Cell Cycle Regulation and Self-Renewal Maintenance</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Viatour</surname><given-names>Patrick</given-names></name>
<xref ref-type="aff" rid="aff1-1947601913481355">1</xref>
<xref ref-type="aff" rid="aff2-1947601913481355">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-1947601913481355"><label>1</label>Center for Childhood Cancer Research, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA</aff>
<aff id="aff2-1947601913481355"><label>2</label>Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA</aff>
<author-notes>
<corresp id="corresp1-1947601913481355">Patrick Viatour, The Children’s Hospital of Philadelphia, 3501 Civic Center Boulevard, Colket Translational Research Building, Room 4064, Philadelphia, PA 19104, USA (Email: <email>viatourp@email.chop.edu</email>).</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>11</month>
<year>2012</year>
</pub-date>
<volume>3</volume>
<issue>11-12</issue>
<fpage>670</fpage>
<lpage>677</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Stem cells are a unique population that lies at the summit of any, or at least most, biological systems. They can differentiate in a variety of mature cell types, but they also have the ability to self-renew, that is, the capacity to divide and retain all the features of the mother cell. The regulation of self-renewal has been studied for many years, but several aspects of this regulation are still vague. The combined decision to divide and self-renew or differentiate suggests that the mechanisms that regulate self-renewal and cell cycle activity are intermingled. While inactivation of many cell cycle regulators impacts the physiological and pathological biology of stem cells, the exact mechanisms that link the decision to enter the cell cycle and the choice of the cellular fate are poorly understood. The multiplicity of signals and pathways regulating self-renewal add to the complexity of the phenomenon. Here, I will review the described links between the cell cycle and self-renewal and discuss the role of the niche in the regulation of both mechanisms.</p>
</abstract>
<kwd-group>
<kwd>cell cycle</kwd>
<kwd>self-renewal</kwd>
<kwd>ES cells</kwd>
<kwd>HSCs</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>November/December 2012</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="section1-1947601913481355" sec-type="intro">
<title>Introduction</title>
<p>Stem cells lie at the apex of a biological system, and they have the unique capacity to either self-renew or differentiate to ultimately produce <italic>de novo</italic> mature effector cells. Specifically, stem cells are defined as a population that is pluripotent, multipotent, or totipotent, which means that they can differentiate into either a defined number of mature lineages (often corresponding to a particular biological system or organ) or into a multitude of lineages found in the body. Briefly, stem cells can be roughly divided into different classes of stem cells (embryonic, germ, induced pluripotent, and adult stem cells), and the current view is that most adult organs contain a limited population of stem cells that can generate <italic>de novo</italic> mature cells either to counteract physiological turnover or to repopulate a cellular compartment that has been damaged by a particular insult.</p>
<p>Human and mouse embryonic stem cells have been extensively studied during the last 2 decades.<sup><xref ref-type="bibr" rid="bibr1-1947601913481355">1</xref>,<xref ref-type="bibr" rid="bibr2-1947601913481355">2</xref></sup> A major difference between embryonic and adult stem cells lies in the regulation of cell cycle activity: while embryonic stem cells display extensive proliferation,<sup><xref ref-type="bibr" rid="bibr3-1947601913481355">3</xref></sup> adult stem cells are often highly quiescent,<sup><xref ref-type="bibr" rid="bibr4-1947601913481355">4</xref></sup> although there are variations among different organs. Indeed, stem cells in intestinal<sup><xref ref-type="bibr" rid="bibr5-1947601913481355">5</xref></sup> and skin<sup><xref ref-type="bibr" rid="bibr6-1947601913481355">6</xref></sup> epithelia, for example, exhibit a robust cell cycle activity.</p>
<p>In addition to differentiation into mature lineages, stem cells also have the choice to symmetrically or asymmetrically divide into new daughter stem cells, a phenomenon commonly described as self-renewal.<sup><xref ref-type="bibr" rid="bibr7-1947601913481355">7</xref></sup> Self-renewal can be considered not only as an active property of stem cells to retain their identity by activating a program of genes that maintain their stem cell status, but it can also be seen as the active repression of genetic programs that promote cellular differentiation.<sup><xref ref-type="bibr" rid="bibr7-1947601913481355">7</xref></sup> In both cases, the result is the generation of new daughter cells that exhibit similar self-renewal and differentiation capacities compared to the mother cell.</p>
<p>An important and inherent aspect of differentiation is the capacity for cells to enter and appropriately regulate cell division. A complex network of genes and pathways regulates the progression of cells through cellular division, and cell cycle activity is often divided into 4 separate phases.<sup><xref ref-type="bibr" rid="bibr8-1947601913481355">8</xref></sup> Quiescent cells are in the G<sub>0</sub> phase, and a variety of proliferative stimuli can trigger the entry of cells into the G<sub>1</sub> phase, which is followed by the S and G<sub>2</sub>/M phases. While the different phases are independently controlled by distinct cell cycle regulators, the G<sub>1</sub> phase is under the most developed regulation by strongly conserved genes.<sup><xref ref-type="bibr" rid="bibr9-1947601913481355">9</xref></sup> This regulation is enforced by the Rb pathway, which includes the Rb family members as well as various members of cyclins and cyclin-dependent kinases.<sup><xref ref-type="bibr" rid="bibr10-1947601913481355">10</xref></sup> Regulation of cell cycle status is an important feature of stem cells, and the recent literature suggests that both cell cycle and self-renewal activities are regulated by common sets of genes and pathways.<sup><xref ref-type="bibr" rid="bibr11-1947601913481355">11</xref></sup></p>
<p>Here, we will review the role of established cell cycle regulators in the control of self-renewal activity. We will focus on embryonic and adult hematopoietic stem cells, as their cell cycle activity is very different, suggesting different ways to regulate self-renewal. As we will see, both extrinsic and intrinsic factors regulate self-renewal status, and we will investigate the connections between cell cycle regulation and these extrinsic/intrinsic factors.</p>
</sec>
<sec id="section2-1947601913481355">
<title>Role of Cell Cycle Regulators in Stem Cell Maintenance</title>
<sec id="section3-1947601913481355">
<title>Embryonic Stem Cells</title>
<p>Mouse embryonic stem (ES) cells originate from the inner cell mass of the blastocyst at the very early step of embryonic development, and they are totipotent, which means that they can differentiate into all cell types found in the body.<sup><xref ref-type="bibr" rid="bibr12-1947601913481355">12</xref></sup> While mouse ES cells have been studied for over 30 years, the last decade has seen tremendous progress in our understanding of human ES cells.<sup><xref ref-type="bibr" rid="bibr2-1947601913481355">2</xref></sup> Both human and mouse ES cells display somewhat similar mechanisms of self-renewal and cell cycle regulation, and we will mostly describe the regulation of these 2 biological activities in mouse ES cells.</p>
<sec id="section4-1947601913481355">
<title>External Factors</title>
<p>Mouse ES cells can easily be cultured <italic>in vitro</italic>, and their successful maintenance in an undifferentiated state can be achieved by adding defined factors to the culture media. Leukemia inhibitory factor (LIF) has been the first identified factor that promotes self-renewal in ES cells.<sup><xref ref-type="bibr" rid="bibr13-1947601913481355">13</xref></sup> Indeed, LIF treatment can substitute for culture on feeders. LIF mostly acts through the Jak/Stat pathway,<sup><xref ref-type="bibr" rid="bibr14-1947601913481355">14</xref></sup> but its exact downstream effectors are poorly identified, although a role for Myc in LIF-mediated self-renewal has been suggested.<sup><xref ref-type="bibr" rid="bibr15-1947601913481355">15</xref></sup> Recently, more external factors have been shown to play a role in the maintenance of self-renewal, including bone morphogenetic protein (BMP) signaling and Wnt signaling.<sup><xref ref-type="bibr" rid="bibr16-1947601913481355">16</xref>,<xref ref-type="bibr" rid="bibr17-1947601913481355">17</xref></sup> These different signals work in collaboration to prodifferentiation signals, such as the MAPK cascade. Interestingly, Wnt3a works in a paracrine and autocrine manner, suggesting that the boundaries between internal and external factors may be an obsolete concept.<sup><xref ref-type="bibr" rid="bibr17-1947601913481355">17</xref></sup></p>
</sec>
<sec id="section5-1947601913481355">
<title>Internal Factors</title>
<sec id="section6-1947601913481355">
<title>Transcription factors: Oct4, Nanog, and Sox2 take center stage</title>
<p>ES cells rely on a limited number of transcription factors to ensure the maintenance of their undifferentiated state. Within that short list, Oct4, Sox2, and Nanog are critically important to promote self-renewal in ES cells.<sup><xref ref-type="bibr" rid="bibr18-1947601913481355">18</xref></sup> These 3 transcription factors bind to overlapping as well as distinct promoter regions to repress the expression of genes that promote cellular differentiation.<sup><xref ref-type="bibr" rid="bibr19-1947601913481355">19</xref></sup> In addition, recent work has identified Ronin as another factor whose expression is critical for ES cell maintenance.<sup><xref ref-type="bibr" rid="bibr20-1947601913481355">20</xref></sup> In a noncanonical mode, it has been shown that caspase-3 can cleave both Ronin and Nanog, thereby inducing differentiation.<sup><xref ref-type="bibr" rid="bibr21-1947601913481355">21</xref></sup></p>
</sec>
<sec id="section7-1947601913481355">
<title>miRNAs specific to ES cell maintenance</title>
<p>The overall role of miRNAs in ES cells is to promote proliferation and differentiation.<sup><xref ref-type="bibr" rid="bibr22-1947601913481355">22</xref>,<xref ref-type="bibr" rid="bibr23-1947601913481355">23</xref></sup> This was suggested by results generated in Dicer- and Dgcr8-deficient ES cells: these ES cells have a lower proliferation index and maintain their pluripotent potential, even in culture conditions that promote differentiation.<sup><xref ref-type="bibr" rid="bibr23-1947601913481355">23</xref>,<xref ref-type="bibr" rid="bibr24-1947601913481355">24</xref></sup> In fact, a reduced number of miRNAs are expressed in ES cells.<sup><xref ref-type="bibr" rid="bibr25-1947601913481355">25</xref></sup> One of the main goals of mir-290 and mir-302 is to promote high cell cycle activity by targeting numerous components of the cell cycle regulatory machinery, including members of the cyclin-dependent kinase inhibitor and Rb family.<sup><xref ref-type="bibr" rid="bibr22-1947601913481355">22</xref>,<xref ref-type="bibr" rid="bibr26-1947601913481355">26</xref><xref ref-type="bibr" rid="bibr27-1947601913481355"/>-<xref ref-type="bibr" rid="bibr28-1947601913481355">28</xref></sup> As a result, the G<sub>1</sub>/S transition, the main point of control for the cell cycle, is accelerated, and ES cells have high proliferative activity. Not surprisingly, these miRNAs are under positive transcriptional regulation by the pluripotency factors Oct4, Sox2, and Nanog.<sup><xref ref-type="bibr" rid="bibr29-1947601913481355">29</xref></sup> The same 3 transcription factors also repress the expression of miRNAs that promote differentiation of ES cells, including mir-145, mir-134, mir-296, mir-470, mir-200c, and mir-183, and members of the Polycomb group of proteins (see below) are involved in the silencing of these target miRNAs.<sup><xref ref-type="bibr" rid="bibr29-1947601913481355">29</xref></sup> Interestingly, target genes of these miRNAs include Oct4, Sox2, and Nanog, thereby generating a negative feedback loop.<sup><xref ref-type="bibr" rid="bibr30-1947601913481355">30</xref></sup> Finally, the expression of let-7 promotes differentiation, and let-7 expression is repressed by pluripotency factors, such as Lin28B.<sup><xref ref-type="bibr" rid="bibr31-1947601913481355">31</xref>,<xref ref-type="bibr" rid="bibr32-1947601913481355">32</xref></sup></p>
</sec>
<sec id="section8-1947601913481355">
<title>Regulation of chromatin state</title>
<p>Expression of factors that promote differentiation in ES cells is also tightly regulated at the chromatin level. Two groups of chromatin regulators compete for an appropriate methylation status: Polycomb and Trithorax proteins modulate the state of chromatin by methylating different lysine residues, H3K7 (repression) and H3K4 (activation), respectively. Indeed, it has been shown that loss of the expression of key Polycomb genes promotes ES cell differentiation.<sup><xref ref-type="bibr" rid="bibr33-1947601913481355">33</xref>,<xref ref-type="bibr" rid="bibr34-1947601913481355">34</xref></sup></p>
</sec></sec>
<sec id="section9-1947601913481355">
<title>Cell Cycle Regulators</title>
<p>Cell cycle activity is very high in ES cells, with a shortened G<sub>1</sub>/S transition. Rb family proteins are heavily phosphorylated and therefore functionally inactivated.<sup><xref ref-type="bibr" rid="bibr3-1947601913481355">3</xref>,<xref ref-type="bibr" rid="bibr35-1947601913481355">35</xref></sup> As a consequence, genes that are involved in cell division are constantly “on,” leading to a reduced population in the G<sub>0</sub> quiescence state. Interestingly, while the p53 expression level is high in ES cells, the capacity for p53 to activate its canonical program in a normal condition is still unclear, and ES cells are uniquely insensitive to DNA damage–induced, p53-mediated cell cycle arrest.<sup><xref ref-type="bibr" rid="bibr36-1947601913481355">36</xref></sup> However, several lines of evidence point to an important role for p53 in the control of self-renewal and differentiation in ES cells. The first evidence comes from its ability to repress Nanog expression (as well as Oct4 in human ES cells).<sup><xref ref-type="bibr" rid="bibr37-1947601913481355">37</xref>,<xref ref-type="bibr" rid="bibr38-1947601913481355">38</xref></sup> Decreased expression of these factors is sufficient to impair self-renewal in ES cells. However, p53 also promotes differentiation by activating the expression of several miRNAs. An important effector of p53 is the mir-34 family, which directly targets Nanog for silencing,<sup><xref ref-type="bibr" rid="bibr39-1947601913481355">39</xref>,<xref ref-type="bibr" rid="bibr40-1947601913481355">40</xref></sup> as well as Lin28,<sup><xref ref-type="bibr" rid="bibr41-1947601913481355">41</xref></sup> which maintains self-renewal by repressing let-7 expression. Other miRNAs transcriptionally activated by p53 include mir-145, mir-200, mir-107, and mir-194.<sup><xref ref-type="bibr" rid="bibr42-1947601913481355">42</xref></sup> These miRNAs target multiple components of the machinery that maintains ES cells in an undifferentiated state. While all these elements point to the prodifferentiation activity of p53, it is also of interest to note that p53 can promote ES cell maintenance by activating the expression of several Wnt ligands.<sup><xref ref-type="bibr" rid="bibr43-1947601913481355">43</xref></sup> These data suggest an important role for p53 in the control of ES cell self-renewal. In contrast, surprisingly little is known about the role of Rb proteins and the different components of the Rb pathway in the same activity.<sup><xref ref-type="bibr" rid="bibr44-1947601913481355">44</xref></sup></p>
</sec></sec>
<sec id="section10-1947601913481355">
<title>Adult Stem Cells</title>
<sec id="section11-1947601913481355">
<title>Hematopoietic Stem Cells</title>
<p>Hematopoietic stem cells (HSCs) have served as a paradigm for the study of adult stem cell biology. Since their identification more than 15 years ago, the scientific community has identified a hierarchy of stem and progenitor cells that contribute to the constant replacement of cells from the lymphoid and myeloid lineage.<sup><xref ref-type="bibr" rid="bibr45-1947601913481355">45</xref></sup> In contrast to ES cells, HSCs are mostly quiescent and only exit cell cycle arrest to either self-renew or differentiate into the various mature populations of the hematopoietic system.<sup><xref ref-type="bibr" rid="bibr4-1947601913481355">4</xref></sup> It is generally thought that the disruption of HSC quiescence is associated with a decrease in self-renewal (see below), but exceptions have been found to this rule, and the mechanisms that connect cell cycle status and self-renewal activity are only poorly understood.<sup><xref ref-type="bibr" rid="bibr11-1947601913481355">11</xref></sup> Under physiological conditions, HSCs are mostly found in the bone marrow. It is now established that long-term HSCs are settled in a specific environment, frequently described as a niche, which regulates HSC functions through different signals.<sup><xref ref-type="bibr" rid="bibr46-1947601913481355">46</xref></sup> In addition to these external signals, previous studies have shown that several factors could influence stem cell biology in a cell-autonomous manner.<sup><xref ref-type="bibr" rid="bibr47-1947601913481355">47</xref></sup> As the external signals influence the internal circuitry of stem cells, an interesting perspective is the regulation of niche signaling by these internal factors (see <xref ref-type="fig" rid="fig1-1947601913481355">Figure 1</xref>).</p>
<fig id="fig1-1947601913481355" position="float">
<label>Figure 1.</label>
<caption>
<p>External and internal promoters of self-renewal in HSCs. As illustrated, multiple cell types are involved in the regulation of self-renewal of HSCs, including osteoblasts (OB), endothelial cells, mesenchymal cells (MS), and a specific subpopulation of macrophages (Mc). See text for further details on their respective contributions.</p>
</caption>
<graphic xlink:href="10.1177_1947601913481355-fig1.tif"/>
</fig>
<sec id="section12-1947601913481355">
<title>External factors</title>
<p>The HSC niche is a highly complex environment that is only partially described. It appears to be constituted by different cell types (recently reviewed in Ehninger <italic>et al</italic>.<sup><xref ref-type="bibr" rid="bibr46-1947601913481355">46</xref></sup>) that co-exist to provide HSCs with several signals in order to maintain a constant population of HSCs. A recent model suggests the co-existence of 2 related but distinct niches. One, the endosteal niche, is in close proximity to the endosteum and is lined with osteoblasts and a heterogenous population of mesenchymal cells. In addition, that niche also includes a population of endothelial cells. This niche is supposed to host a population of highly quiescent stem cells, and the different populations of cells composing the niche maintain the quiescence and self-renewal of HSCs by expressing at their different surface factors.<sup><xref ref-type="bibr" rid="bibr48-1947601913481355">48</xref>,<xref ref-type="bibr" rid="bibr49-1947601913481355">49</xref></sup> In addition, a second niche, the endothelial niche, is also composed of mesenchymal and endothelial cells but appears to lack any osteoblastic population. This niche would preferentially host active, cycling, and/or self-renewing HSCs. It is not clear what the interactions between these niches are and whether this model is static or dynamic, with stem cells shuttling between the 2 niches.<sup><xref ref-type="bibr" rid="bibr46-1947601913481355">46</xref></sup> Osteoblasts, which are only found in the endosteal niche, appear to be the unique provider of thrombopoietin (TPO), which binds the MPL receptor expressed at the surface of HSCs.<sup><xref ref-type="bibr" rid="bibr50-1947601913481355">50</xref>,<xref ref-type="bibr" rid="bibr51-1947601913481355">51</xref></sup> TPO promotes self-renewal and quiescence by activating the Jak2 cascade. Interestingly, Lnk is a negative regulator of HSC self-renewal by negatively affecting the TPO/MPL/Jak2 cascade. Indeed, Lnk-deficient mice exhibit an increased number of HSCs, and it was shown that the main action of Lnk is to inhibit Jak2 signaling. As a consequence of the failed inhibition of Jak signaling, Lnk-deficient mice also develop an accumulation of myeloid cells over time.<sup><xref ref-type="bibr" rid="bibr52-1947601913481355">52</xref>,<xref ref-type="bibr" rid="bibr53-1947601913481355">53</xref></sup> Osteoblasts are also a source (but maybe not the only one) of angiopoietin-1, which binds to the Tie-2 receptor expressed at the surface of HSCs.<sup><xref ref-type="bibr" rid="bibr54-1947601913481355">54</xref></sup> This interaction also promotes quiescence and homeostasis in HSCs. A series of other factors are also expressed at the surface of cells found in the niche, and these factors, including SCF, CXCl12, N-cadherin, osteopontin, Wnt, Notch, and Tgfb/BMP, also promote stem cell quiescence.<sup><xref ref-type="bibr" rid="bibr46-1947601913481355">46</xref></sup> More specifically, while an initial report described a nonessential role to promote self-renewal in physiological conditions for Notch,<sup><xref ref-type="bibr" rid="bibr55-1947601913481355">55</xref></sup> more recent work suggests that this effect is only transient, and long-term effects include a depletion of the stem cell pool.<sup><xref ref-type="bibr" rid="bibr56-1947601913481355">56</xref></sup> A major caveat of the studies that have reported these findings is the absence of deletion of these factors in specific cell types. As a consequence, it has been difficult so far to establish the exact source of these factors and the contribution of the different cell types to HSC maintenance. A critical question would be whether these factors are expressed, in a redundant manner, by different populations or whether unique populations express specific factors, creating a hierarchy in the cells that populate the niche. A partial answer to that question has recently arisen by suppressing Scf, the ligand for the Kit receptor, in specific populations, one at a time. The Kit receptor (CD119) is expressed at the surface of stem cells and progenitor cells, and it was shown that Scf deletion is only detrimental to the HSC population when it occurs in endothelial cells.<sup><xref ref-type="bibr" rid="bibr57-1947601913481355">57</xref></sup> Endothelial cells seem to be also the exclusive producer of the E-selectin ligand, which promotes HSC proliferation, and inactivation of E-selectin enhances the resistance of HSCs to chemotherapy treatment.<sup><xref ref-type="bibr" rid="bibr58-1947601913481355">58</xref></sup></p>
<p>In addition to these signals that are produced by different populations of the niche, it has also been observed that the general environment of the niche matters. Indeed, the niche is located in an extremely hypoxic environment.<sup><xref ref-type="bibr" rid="bibr59-1947601913481355">59</xref></sup> A low concentration of oxygen and anaerobic metabolism reduce the production of reactive oxygen species (ROS) by stem cells. High intracellular levels of ROS promote the differentiation of HSCs by activating JNK, Pi3K signaling, and inactivating FOXO factors. Indeed, inactivation of FOXO factors leads to the increased production of ROS in stem cells, which is detrimental to the homeostasis of the stem cell pool.<sup><xref ref-type="bibr" rid="bibr60-1947601913481355">60</xref></sup> As a consequence, FOXO1/2/3-deficient stem cells are decreased in number, and their cell cycle activity is promoted. This phenotype can be corrected by N-acetylcysteine (NAC) treatment, which reduces the level of ROS. Interestingly, FOXO1/2/3-deficient mice also develop mild myeloproliferation, which suggests that cell cycle entry is conjugated to the activation of a genetic program that promotes the abnormal development of the myeloid lineage. Quite intriguing is actually the fact that often loss of quiescence is associated with the development of a myeloid disorder (see below). ROS also promote DNA damage, which activates the p53 pathway (see below). The p53 pathway is important for HSC homeostasis, as the ELF4 effect on HSCs is mostly mediated by the MDM2/p53 axis.<sup><xref ref-type="bibr" rid="bibr61-1947601913481355">61</xref></sup> In addition, DNA damage also recruits the ATM kinase, and ATM-deficient mice exhibit higher levels of ROS and a decrease in their HSC population.<sup><xref ref-type="bibr" rid="bibr62-1947601913481355">62</xref></sup> Last, HSCs are also sensitive to a Ca<sup>2+</sup> gradient, and the endosteal niche exhibits a high concentration of Ca<sup>2+</sup> ions. Accordingly, HSCs that are deficient in the calcium receptor have a defect in their migration and homing properties.<sup><xref ref-type="bibr" rid="bibr63-1947601913481355">63</xref></sup></p>
<p>Recent advances in the field have shed light on the phenomenon of asymmetric cell division, that is, the ability of a stem cell to divide into 2 differentiated cells, 2 stem cells, or 1 differentiated cell and 1 stem cell.<sup><xref ref-type="bibr" rid="bibr7-1947601913481355">7</xref></sup> Within the niche, the mother cell is physically connected to the signaling that promotes its maintenance (Wnt, TPO, etc.). Upon its division, based on the spatial availability of the niche, 1 or 2 daughter cells may retain a direct access to signals that will promote its stem cell status. Yet, it is also possible that daughter cells may be physically separated from the source of the signal (osteoblast, mesenchyme cells, etc.), which will induce its differentiation. As a consequence, one mother cell may give birth to 2 stem cells (both connected to the niche), 1 stem cell (connected) and 1 differentiating cell (not connected), or 2 differentiating cells (that are pushed away from the niche). There again, it is not clear whether this model is dynamic, with cells shuttling constantly between different regions of the niche and a different status of differentiation (and self-renewal), or whether it is similar to a 1-way road, where cells can only evolve into a state that is associated with a lower self-renewal status.</p>
<p>Another guest has recently made its entrance in the circle of cells that form the HSC niche. It has been known for a while that granulocyte colony-stimulating factor (G-CSF) treatment can induce the mobilization of HSCs in the periphery, which obviously means to exit the niche.<sup><xref ref-type="bibr" rid="bibr4-1947601913481355">4</xref></sup> As HSCs do not express the receptor for G-CSF, it was recently shown that a population of macrophages serves as an intermediate. Macrophages in the niche promote the activity of mesenchyme and osteoblastic cells, and G-CSF treatment induces the depletion of macrophages from the niche. Therefore, a differentiated population within the hematopoietic compartment can impact the status of HSCs in their niche.<sup><xref ref-type="bibr" rid="bibr64-1947601913481355">64</xref></sup></p>
</sec>
<sec id="section13-1947601913481355">
<title>Internal factors</title>
<p>Many factors have been shown to play a role in the regulation of self-renewal in HSCs. Gfi1 was one of the first genes identified for its role in the maintenance of HSCs. Mice that are deficient in Gfi1 display increased cell cycle activity of HSCs and are outcompeted in transplantation protocols.<sup><xref ref-type="bibr" rid="bibr65-1947601913481355">65</xref></sup> Recent work suggests that Gfi1 promotes HSC maintenance by repressing Bax expression.<sup><xref ref-type="bibr" rid="bibr66-1947601913481355">66</xref></sup> Pbx1 deficiency also induces the cell cycle activity and exhaustion of HSCs, and it is currently suggested that Pbx1 supports HSC self-renewal by promoting TGFβ signaling in HSCs.<sup><xref ref-type="bibr" rid="bibr67-1947601913481355">67</xref></sup> Another factor that promotes TGFβ signaling in HSCs is JunB, and JunB-deficient HSCs have impaired TGFβ and Notch signaling, leading to enhanced cell cycle activity and the onset of a myeloid disorder in these mice.<sup><xref ref-type="bibr" rid="bibr68-1947601913481355">68</xref></sup> Myc is another factor that controls stem cell quiescence, and inactivation of Myc in the hematopoietic compartment leads to cytopenia and an accumulation of HSCs.<sup><xref ref-type="bibr" rid="bibr69-1947601913481355">69</xref></sup> Recent work has shown that deletion of Fbw7 leads to the proliferation and exhaustion of HSCs, and further analysis has shown that the main relevant target for Fbw7 in HSCs is cMyc. Indeed, inactivation of Fbw7 in HSCs leads to an increase in the amount of Myc.<sup><xref ref-type="bibr" rid="bibr70-1947601913481355">70</xref></sup> Finally, deletion of Evi1 is detrimental to the maintenance of HSCs, and the effect appears to be mainly mediated by the regulation of GATA-2 expression by Evi1.<sup><xref ref-type="bibr" rid="bibr71-1947601913481355">71</xref></sup></p>
</sec>
<sec id="section14-1947601913481355">
<title>Cell cycle regulators</title>
<p>The Rb pathway is a critical regulator of the G<sub>1</sub>/S sequence of the cell cycle. The majority of the components of the pathway have been specifically inactivated in the hematopoietic compartment. Components of the Polycomb group have been shown to promote self-renewal in ES cells (see above). In HSCs, it has also been demonstrated that Bmi1 expression promotes self-renewal in HSCs by repressing the expression of p16 and p19.<sup><xref ref-type="bibr" rid="bibr72-1947601913481355">72</xref>,<xref ref-type="bibr" rid="bibr73-1947601913481355">73</xref></sup> This activity is unique among members of the Polycomb groups, suggesting a specific role for Bmi1. Bmi1 also represses the expression of genes that promotes differentiation, such as Ebf1 and Pax5, as well as Ikaros, for the B cell lineage.<sup><xref ref-type="bibr" rid="bibr74-1947601913481355">74</xref></sup> Within the CIP/KIP family, p21 deficiency leads to the extensive proliferation and exhaustion of HSCs.<sup><xref ref-type="bibr" rid="bibr75-1947601913481355">75</xref></sup> However, recent data suggest that p21 activity is only relevant in stressed HSCs.<sup><xref ref-type="bibr" rid="bibr76-1947601913481355">76</xref></sup> In contrast, p27 inactivation did not lead to a defect in the HSC compartment but impacts progenitor proliferation.<sup><xref ref-type="bibr" rid="bibr77-1947601913481355">77</xref></sup> There probably exists a compensation phenomenon within the CIP/KIP family, as double deficiency for p57 and p27 leads to a loss of HSC quiescence. TPO and TGFβ signaling in HSCs induce the expression of p57, which sequesters a complex formed by Hsc70 and cyclin D1 in the cytoplasm. Upon the deficiency of p57 and p27, this complex shuttles to the nucleus to promote the phosphorylation of the Rb family and entry into the cell cycle.<sup><xref ref-type="bibr" rid="bibr78-1947601913481355">78</xref>,<xref ref-type="bibr" rid="bibr79-1947601913481355">79</xref></sup></p>
<p>p16’s role in HSC maintenance is somehow specific, as only aged HSCs are impacted by the loss of p16. p16 seems to promote an age-related decline in the functions of HSCs, probably in response to an accumulated amount of ROS.<sup><xref ref-type="bibr" rid="bibr80-1947601913481355">80</xref></sup> While the general trend associates cell cycle entry to loss of self-renewal, the loss of p18 translated into increased cell cycle activity and concomitant unaltered self-renewal activity. In this case, p18 deficiency would considerably shorten the length of the G<sub>1</sub> phase, thereby bypassing the decision to differentiate.<sup><xref ref-type="bibr" rid="bibr81-1947601913481355">81</xref></sup> Finally, inactivation of the Rb gene is not detrimental to HSC status.<sup><xref ref-type="bibr" rid="bibr82-1947601913481355">82</xref></sup> The Rb family genes (Rb, p107, and p130) display strong overlapping activities, and it is therefore not surprising that the concomitant inactivation of the 3 Rb family members (TKO) is sufficient to lead HSCs to cell cycle re-entry. However, the self-renewal status of TKO HSCs is not yet clear, and additional experiments are required to assess the long-term self-renewal status upon inactivation of the Rb family of genes. As often observed when HSCs are forced to enter the cell cycle, TKO mice display a myeloid disorder. While more work is also required to understand the molecular basis of the phenotype, several key myeloid genes had up-regulated expression in TKO KLS (Kit<sup>+</sup>, Lineage<sup>–</sup>, and Sca1<sup>+</sup> cellular fraction, enriched in stem and early progenitor cell activity) cells, and a possible explanation is that the Rb pathway directly controls their expression. This model would mechanically link proliferation with promotion of the myeloid lineage, at least in adult HSCs.<sup><xref ref-type="bibr" rid="bibr83-1947601913481355">83</xref></sup> Indeed, GATA-2, whose expression in human progenitor cells promotes the enforced differentiation into the eosinophilic lineage,<sup><xref ref-type="bibr" rid="bibr84-1947601913481355">84</xref></sup> seems to be directly regulated by the Rb pathway, through direct binding of E2F transcription factors to its promoter sequence.</p>
<p>Last, p53 promotes the quiescence of HSCs, not so much by inducing p21 expression, whose role in physiological hematopoiesis is limited, but by inducing the expression of Gfi1 and Necdin.<sup><xref ref-type="bibr" rid="bibr85-1947601913481355">85</xref></sup> In addition, p53 limits the self-renewal ability of HSCs, a phenomenon that is also observed in other biological compartments. Interestingly, irradiated HSCs, with a high expression of active p53, have a reduced ability to engraft and contribute to hematopoiesis upon transplantation. While this defect has been associated with a defect in the cell cycle (as p53 promotes cell cycle quiescence),<sup><xref ref-type="bibr" rid="bibr85-1947601913481355">85</xref></sup> another possibility is that p53 impairs the capacity of HSCs to connect and respond to the signal provided by the niche for engraftment.</p>
</sec></sec>
<sec id="section15-1947601913481355">
<title>Other Stem Cell Compartments</title>
<p>In <italic>Arabidopsis thaliana</italic>, Rb deletion leads to the expansion of the stem cell compartment, with combined cell cycle activity and maintenance of self-renewal. Accordingly, overexpression of cyclin D promotes stem cell expansion.<sup><xref ref-type="bibr" rid="bibr86-1947601913481355">86</xref></sup> In other systems such as the brain, skin, and intestine, a niche that controls stem cell functions has been identified, with recurrent roles for similar signals such as Wnt, Notch, or Shh signaling in the maintenance of a stable stem cell population, but the specific role of cell cycle regulators in the maintenance of self-renewal is poorly investigated.<sup><xref ref-type="bibr" rid="bibr5-1947601913481355">5</xref>,<xref ref-type="bibr" rid="bibr6-1947601913481355">6</xref>,<xref ref-type="bibr" rid="bibr87-1947601913481355">87</xref></sup></p>
</sec></sec>
</sec>
<sec id="section16-1947601913481355" sec-type="conclusions">
<title>Concluding Remarks</title>
<p>Stem cells are particularly sensitive to the dysregulated activity of canonical cell cycle regulators. While these cells are highly quiescent, the inactivation of several cell cycle regulators is sufficient to lead them to cell cycle re-entry. Interestingly, and although beyond strictly the scope of this review, while alteration of the Rb pathway is sufficient to trigger stem cell proliferation in the hematopoietic system and in the liver, the same genetic alteration does not modify the cell cycle status of mature populations in the same systems.<sup><xref ref-type="bibr" rid="bibr83-1947601913481355">83</xref>,<xref ref-type="bibr" rid="bibr88-1947601913481355">88</xref></sup> While this is not very surprising in the case of myeloid cells, which are highly quiescent and have terminally exited the cell cycle, the finding that mature hepatocytes cannot re-enter the cell cycle upon a loss of the Rb family of genes is more surprising, especially given the potential of hepatocytes to re-enter the cell cycle when challenged by specific stimuli (such as partial hepatectomy). Alternatively, it was shown recently that loss of Rb and p19 ARF was sufficient to introduce cell cycle activity in postmitotic myocytes, and this was associated with dedifferentiation of these cells.<sup><xref ref-type="bibr" rid="bibr89-1947601913481355">89</xref></sup> Similarly, inactivation of p53 increases the efficiency of induced pluripotent stem cell derivation from various differentiated cell types.<sup><xref ref-type="bibr" rid="bibr90-1947601913481355">90</xref></sup> These data would suggest that components of the cell cycle machinery may link the regulation of cell proliferation to differentiation, although the exact mechanism is certainly context dependent. This hypothesis may be connected to what we have observed in the stem cell compartment. Clearly, stem cells are uniquely sensitive to the deficient expression of components of the cell cycle machinery, and stem cells often exit their quiescence state upon inactivation of several regulators of this machinery. The trade-off seems to be a loss of self-renewal potential of these proliferating stem cells, at least upon the inactivation of several cell cycle regulators, although not all. Indeed, p18 deficiency does not appear to be associated with a loss of self-renewal, and inactivation of the Rb family of genes does not seem to induce a decrease of self-renewal either (see above). As suggested before, this discrepancy in the activity of several cell cycle regulators in the control of self-renewal may be associated with the particular phase of the cell cycle that they are controlling.<sup><xref ref-type="bibr" rid="bibr11-1947601913481355">11</xref></sup> This is illustrated by ES cells, where proliferative ES cells are kept in an undifferentiated state, and this high self-renewal activity is linked to the very short G<sub>1</sub>/S phase that is unique to these ES cells.</p>
<p>Regulators of self-renewal status are often classified as external regulators (signals produced by the niche to promote self-renewal) and internal factors. The role of these internal factors is often described as mostly involved in the regulation of intracellular processes. However, work on the Lnk gene, for example, has shown that the main activity of this factor is to precisely modulate TPO signaling, therefore integrating the external with internal maintenance of self-renewal.<sup><xref ref-type="bibr" rid="bibr52-1947601913481355">52</xref></sup> In the case of components of the cell cycle machinery, it is probable that they directly control the decision to self-renew or differentiate (as illustrated by the capacity for Bmi1 to repress p16 and p19 expression, but also factors that promote the B cell lineage). However, given the ever-expanding role of these genes in various cellular activities, it is also plausible that cell cycle genes directly interact and regulate the external signaling that promotes self-renewal. In the complexity of self-renewal regulation, the fact that a mature hematopoietic population can regulate the self-renewal activity of HSCs suggests that cell cycle regulators (or other genes that control self-renewal) may also play a distinct role in different populations of the same system.<sup><xref ref-type="bibr" rid="bibr64-1947601913481355">64</xref></sup> As traditional methods lead to the deletion of a particular gene of interest in an entire compartment, this phenomenon may have been overlooked in the past. Clearly, future studies will require the deletion of genes of interest in very specific populations of the niche and the different cell types of a biological system. These studies should shed light on the role of cell cycle regulators in the control of stem cell self-renewal, which probably includes a mix of direct regulation of genes involved in differentiation and fine-tuning of signals that modulate self-renewal.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The author(s) received the following financial support for the research, authorship, and/or publication of this article: The Viatour laboratory is supported by institutional division funds from the Center for Childhood Cancer Research at The Children’s Hospital of Philadelphia and the WW Smith Charitable Trust Foundation.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1947601913481355">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thomson</surname><given-names>JA</given-names></name>
<name><surname>Marshall</surname><given-names>VS</given-names></name>
</person-group>. <article-title>Primate embryonic stem cells</article-title>. <source>Curr Top Dev Biol</source>. <year>1998</year>;<volume>38</volume>: <fpage>133</fpage>-<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr2-1947601913481355">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thomson</surname><given-names>JA</given-names></name>
<name><surname>Itskovitz-Eldor</surname><given-names>J</given-names></name>
<name><surname>Shapiro</surname><given-names>SS</given-names></name>
<etal/></person-group>. <article-title>Embryonic stem cell lines derived from human blastocysts</article-title>. <source>Science</source>. <year>1998</year>;<volume>282</volume>:<fpage>1145</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr3-1947601913481355">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Burdon</surname><given-names>T</given-names></name>
<name><surname>Smith</surname><given-names>A</given-names></name>
<name><surname>Savatier</surname><given-names>P</given-names></name>
</person-group>. <article-title>Signalling, cell cycle and pluripotency in embryonic stem cells</article-title>. <source>Trends Cell Biol</source>. <year>2002</year>;<volume>12</volume>:<fpage>432</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr4-1947601913481355">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Passegue</surname><given-names>E</given-names></name>
<name><surname>Wagers</surname><given-names>AJ</given-names></name>
<name><surname>Giuriato</surname><given-names>S</given-names></name>
<name><surname>Anderson</surname><given-names>WC</given-names></name>
<name><surname>Weissman</surname><given-names>IL</given-names></name>
</person-group>. <article-title>Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates</article-title>. <source>J Exp Med</source>. <year>2005</year>;<volume>202</volume>:<fpage>1599</fpage>-<lpage>611</lpage>.</citation>
</ref>
<ref id="bibr5-1947601913481355">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Simons</surname><given-names>BD</given-names></name>
<name><surname>Clevers</surname><given-names>H</given-names></name>
</person-group>. <article-title>Stem cell self-renewal in intestinal crypt</article-title>. <source>Exp Cell Res</source>. <year>2011</year>;<volume>317</volume>:<fpage>2719</fpage>-<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr6-1947601913481355">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beck</surname><given-names>B</given-names></name>
<name><surname>Blanpain</surname><given-names>C</given-names></name>
</person-group>. <article-title>Mechanisms regulating epidermal stem cells</article-title>. <source>EMBO J</source>. <year>2012</year>;<volume>31</volume>:<fpage>2067</fpage>-<lpage>75</lpage>.</citation>
</ref>
<ref id="bibr7-1947601913481355">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Simons</surname><given-names>BD</given-names></name>
<name><surname>Clevers</surname><given-names>H</given-names></name>
</person-group>. <article-title>Strategies for homeostatic stem cell self-renewal in adult tissues</article-title>. <source>Cell</source>. <year>2011</year>;<volume>145</volume>:<fpage>851</fpage>-<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr8-1947601913481355">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bloom</surname><given-names>J</given-names></name>
<name><surname>Cross</surname><given-names>FR</given-names></name>
</person-group>. <article-title>Multiple levels of cyclin specificity in cell-cycle control</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2007</year>;<volume>8</volume>:<fpage>149</fpage>-<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr9-1947601913481355">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weinberg</surname><given-names>RA</given-names></name>
</person-group>. <article-title>The retinoblastoma protein and cell cycle control</article-title>. <source>Cell</source>. <year>1995</year>;<volume>81</volume>:<fpage>323</fpage>-<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr10-1947601913481355">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Burkhart</surname><given-names>DL</given-names></name>
<name><surname>Sage</surname><given-names>J</given-names></name>
</person-group>. <article-title>Cellular mechanisms of tumour suppression by the retinoblastoma gene</article-title>. <source>Nat Rev Cancer</source>. <year>2008</year>;<volume>8</volume>:<fpage>671</fpage>-<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr11-1947601913481355">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Orford</surname><given-names>KW</given-names></name>
<name><surname>Scadden</surname><given-names>DT</given-names></name>
</person-group>. <article-title>Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation</article-title>. <source>Nat Rev Genet</source>. <year>2008</year>;<volume>9</volume>:<fpage>115</fpage>-<lpage>28</lpage>.</citation>
</ref>
<ref id="bibr12-1947601913481355">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tesar</surname><given-names>PJ</given-names></name>
<name><surname>Chenoweth</surname><given-names>JG</given-names></name>
<name><surname>Brook</surname><given-names>FA</given-names></name>
<etal/></person-group>. <article-title>New cell lines from mouse epiblast share defining features with human embryonic stem cells</article-title>. <source>Nature</source>. <year>2007</year>;<volume>448</volume>:<fpage>196</fpage>-<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr13-1947601913481355">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Williams</surname><given-names>RL</given-names></name>
<name><surname>Hilton</surname><given-names>DJ</given-names></name>
<name><surname>Pease</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells</article-title>. <source>Nature</source>. <year>1988</year>;<volume>336</volume>:<fpage>684</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr14-1947601913481355">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Niwa</surname><given-names>H</given-names></name>
<name><surname>Burdon</surname><given-names>T</given-names></name>
<name><surname>Chambers</surname><given-names>I</given-names></name>
<name><surname>Smith</surname><given-names>A</given-names></name>
</person-group>. <article-title>Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3</article-title>. <source>Genes Dev</source>. <year>1998</year>;<volume>12</volume>:<fpage>2048</fpage>-<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr15-1947601913481355">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cartwright</surname><given-names>P</given-names></name>
<name><surname>McLean</surname><given-names>C</given-names></name>
<name><surname>Sheppard</surname><given-names>A</given-names></name>
<name><surname>Rivett</surname><given-names>D</given-names></name>
<name><surname>Jones</surname><given-names>K</given-names></name>
<name><surname>Dalton</surname><given-names>S</given-names></name>
</person-group>. <article-title>LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism</article-title>. <source>Development</source>. <year>2005</year>;<volume>132</volume>:<fpage>885</fpage>-<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr16-1947601913481355">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ying</surname><given-names>QL</given-names></name>
<name><surname>Nichols</surname><given-names>J</given-names></name>
<name><surname>Chambers</surname><given-names>I</given-names></name>
<name><surname>Smith</surname><given-names>A</given-names></name>
</person-group>. <article-title>BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3</article-title>. <source>Cell</source>. <year>2003</year>;<volume>115</volume>:<fpage>281</fpage>-<lpage>92</lpage>.</citation>
</ref>
<ref id="bibr17-1947601913481355">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>ten Berge</surname><given-names>D</given-names></name>
<name><surname>Kurek</surname><given-names>D</given-names></name>
<name><surname>Blauwkamp</surname><given-names>T</given-names></name>
<etal/></person-group>. <article-title>Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells</article-title>. <source>Nat Cell Biol</source>. <year>2011</year>;<volume>13</volume>:<fpage>1070</fpage>-<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr18-1947601913481355">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dejosez</surname><given-names>M</given-names></name>
<name><surname>Zwaka</surname><given-names>TP</given-names></name>
</person-group>. <article-title>Pluripotency and nuclear reprogramming</article-title>. <source>Annu Rev Biochem</source>. <year>2012</year>;<volume>81</volume>:<fpage>737</fpage>-<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr19-1947601913481355">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jaenisch</surname><given-names>R</given-names></name>
<name><surname>Young</surname><given-names>R</given-names></name>
</person-group>. <article-title>Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming</article-title>. <source>Cell</source>. <year>2008</year>;<volume>132</volume>:<fpage>567</fpage>-<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr20-1947601913481355">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dejosez</surname><given-names>M</given-names></name>
<name><surname>Krumenacker</surname><given-names>JS</given-names></name>
<name><surname>Zitur</surname><given-names>LJ</given-names></name>
<etal/></person-group>. <article-title>Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells</article-title>. <source>Cell</source>. <year>2008</year>;<volume>133</volume>:<fpage>1162</fpage>-<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr21-1947601913481355">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fujita</surname><given-names>J</given-names></name>
<name><surname>Crane</surname><given-names>AM</given-names></name>
<name><surname>Souza</surname><given-names>MK</given-names></name>
<etal/></person-group>. <article-title>Caspase activity mediates the differentiation of embryonic stem cells</article-title>. <source>Cell Stem Cell</source>. <year>2008</year>;<volume>2</volume>:<fpage>595</fpage>-<lpage>601</lpage>.</citation>
</ref>
<ref id="bibr22-1947601913481355">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Y</given-names></name>
<name><surname>Baskerville</surname><given-names>S</given-names></name>
<name><surname>Shenoy</surname><given-names>A</given-names></name>
<name><surname>Babiarz</surname><given-names>JE</given-names></name>
<name><surname>Baehner</surname><given-names>L</given-names></name>
<name><surname>Blelloch</surname><given-names>R</given-names></name>
</person-group>. <article-title>Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation</article-title>. <source>Nat Genet</source>. <year>2008</year>;<volume>40</volume>:<fpage>1478</fpage>-<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr23-1947601913481355">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Y</given-names></name>
<name><surname>Medvid</surname><given-names>R</given-names></name>
<name><surname>Melton</surname><given-names>C</given-names></name>
<name><surname>Jaenisch</surname><given-names>R</given-names></name>
<name><surname>Blelloch</surname><given-names>R</given-names></name>
</person-group>. <article-title>DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal</article-title>. <source>Nat Genet</source>. <year>2007</year>;<volume>39</volume>:<fpage>380</fpage>-<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr24-1947601913481355">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Murchison</surname><given-names>EP</given-names></name>
<name><surname>Partridge</surname><given-names>JF</given-names></name>
<name><surname>Tam</surname><given-names>OH</given-names></name>
<name><surname>Cheloufi</surname><given-names>S</given-names></name>
<name><surname>Hannon</surname><given-names>GJ</given-names></name>
</person-group>. <article-title>Characterization of Dicer-deficient murine embryonic stem cells</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2005</year>;<volume>102</volume>:<fpage>12135</fpage>-<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr25-1947601913481355">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gangaraju</surname><given-names>VK</given-names></name>
<name><surname>Lin</surname><given-names>H</given-names></name>
</person-group>. <article-title>MicroRNAs: key regulators of stem cells</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2009</year>;<volume>10</volume>:<fpage>116</fpage>-<lpage>25</lpage>.</citation>
</ref>
<ref id="bibr26-1947601913481355">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Martinez</surname><given-names>NJ</given-names></name>
<name><surname>Gregory</surname><given-names>RI</given-names></name>
</person-group>. <article-title>MicroRNA gene regulatory pathways in the establishment and maintenance of ESC identity</article-title>. <source>Cell Stem Cell</source>. <year>2010</year>;<volume>7</volume>:<fpage>31</fpage>-<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr27-1947601913481355">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Subramanyam</surname><given-names>D</given-names></name>
<name><surname>Lamouille</surname><given-names>S</given-names></name>
<name><surname>Judson</surname><given-names>RL</given-names></name>
<etal/></person-group>. <article-title>Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells</article-title>. <source>Nat Biotechnol</source>. <year>2011</year>;<volume>29</volume>:<fpage>443</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr28-1947601913481355">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Card</surname><given-names>DA</given-names></name>
<name><surname>Hebbar</surname><given-names>PB</given-names></name>
<name><surname>Li</surname><given-names>L</given-names></name>
<etal/></person-group>. <article-title>Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells</article-title>. <source>Mol Cell Biol</source>. <year>2008</year>;<volume>28</volume>:<fpage>6426</fpage>-<lpage>38</lpage>.</citation>
</ref>
<ref id="bibr29-1947601913481355">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marson</surname><given-names>A</given-names></name>
<name><surname>Levine</surname><given-names>SS</given-names></name>
<name><surname>Cole</surname><given-names>MF</given-names></name>
<etal/></person-group>. <article-title>Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells</article-title>. <source>Cell</source>. <year>2008</year>;<volume>134</volume>:<fpage>521</fpage>-<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr30-1947601913481355">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wellner</surname><given-names>U</given-names></name>
<name><surname>Schubert</surname><given-names>J</given-names></name>
<name><surname>Burk</surname><given-names>UC</given-names></name>
<etal/></person-group>. <article-title>The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs</article-title>. <source>Nat Cell Biol</source>. <year>2009</year>;<volume>11</volume>:<fpage>1487</fpage>-<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr31-1947601913481355">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Viswanathan</surname><given-names>SR</given-names></name>
<name><surname>Daley</surname><given-names>GQ</given-names></name>
<name><surname>Gregory</surname><given-names>RI</given-names></name>
</person-group>. <article-title>Selective blockade of microRNA processing by Lin28</article-title>. <source>Science</source>. <year>2008</year>;<volume>320</volume>:<fpage>97</fpage>-<lpage>100</lpage>.</citation>
</ref>
<ref id="bibr32-1947601913481355">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bar</surname><given-names>M</given-names></name>
<name><surname>Wyman</surname><given-names>SK</given-names></name>
<name><surname>Fritz</surname><given-names>BR</given-names></name>
<etal/></person-group>. <article-title>MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries</article-title>. <source>Stem Cells</source>. <year>2008</year>;<volume>26</volume>:<fpage>2496</fpage>-<lpage>505</lpage>.</citation>
</ref>
<ref id="bibr33-1947601913481355">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schuettengruber</surname><given-names>B</given-names></name>
<name><surname>Chourrout</surname><given-names>D</given-names></name>
<name><surname>Vervoort</surname><given-names>M</given-names></name>
<name><surname>Leblanc</surname><given-names>B</given-names></name>
<name><surname>Cavalli</surname><given-names>G</given-names></name>
</person-group>. <article-title>Genome regulation by Polycomb and Trithorax proteins</article-title>. <source>Cell</source>. <year>2007</year>;<volume>128</volume>:<fpage>735</fpage>-<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr34-1947601913481355">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mikkelsen</surname><given-names>TS</given-names></name>
<name><surname>Ku</surname><given-names>M</given-names></name>
<name><surname>Jaffe</surname><given-names>DB</given-names></name>
<etal/></person-group>. <article-title>Genome-wide maps of chromatin state in pluripotent and lineage-committed cells</article-title>. <source>Nature</source>. <year>2007</year>;<volume>448</volume>:<fpage>553</fpage>-<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr35-1947601913481355">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stead</surname><given-names>E</given-names></name>
<name><surname>White</surname><given-names>J</given-names></name>
<name><surname>Faast</surname><given-names>R</given-names></name>
<etal/></person-group>. <article-title>Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities</article-title>. <source>Oncogene</source>. <year>2002</year>;<volume>21</volume>:<fpage>8320</fpage>-<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr36-1947601913481355">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Solozobova</surname><given-names>V</given-names></name>
<name><surname>Blattner</surname><given-names>C</given-names></name>
</person-group>. <article-title>Regulation of p53 in embryonic stem cells</article-title>. <source>Exp Cell Res</source>. <year>2010</year>;<volume>316</volume>:<fpage>2434</fpage>-<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr37-1947601913481355">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lin</surname><given-names>T</given-names></name>
<name><surname>Chao</surname><given-names>C</given-names></name>
<name><surname>Saito</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression</article-title>. <source>Nat Cell Biol</source>. <year>2005</year>;<volume>7</volume>:<fpage>165</fpage>-<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr38-1947601913481355">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maimets</surname><given-names>T</given-names></name>
<name><surname>Neganova</surname><given-names>I</given-names></name>
<name><surname>Armstrong</surname><given-names>L</given-names></name>
<name><surname>Lako</surname><given-names>M</given-names></name>
</person-group>. <article-title>Activation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells</article-title>. <source>Oncogene</source>. <year>2008</year>;<volume>27</volume>:<fpage>5277</fpage>-<lpage>87</lpage>.</citation>
</ref>
<ref id="bibr39-1947601913481355">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>He</surname><given-names>L</given-names></name>
<name><surname>He</surname><given-names>X</given-names></name>
<name><surname>Lim</surname><given-names>LP</given-names></name>
<etal/></person-group>. <article-title>A microRNA component of the p53 tumour suppressor network</article-title>. <source>Nature</source>. <year>2007</year>;<volume>447</volume>:<fpage>1130</fpage>-<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr40-1947601913481355">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chang</surname><given-names>TC</given-names></name>
<name><surname>Wentzel</surname><given-names>EA</given-names></name>
<name><surname>Kent</surname><given-names>OA</given-names></name>
<etal/></person-group>. <article-title>Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis</article-title>. <source>Mol Cell</source>. <year>2007</year>;<volume>26</volume>:<fpage>745</fpage>-<lpage>52</lpage>.</citation>
</ref>
<ref id="bibr41-1947601913481355">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hanna</surname><given-names>J</given-names></name>
<name><surname>Saha</surname><given-names>K</given-names></name>
<name><surname>Pando</surname><given-names>B</given-names></name>
<etal/></person-group>. <article-title>Direct cell reprogramming is a stochastic process amenable to acceleration</article-title>. <source>Nature</source>. <year>2009</year>;<volume>462</volume>:<fpage>595</fpage>-<lpage>601</lpage>.</citation>
</ref>
<ref id="bibr42-1947601913481355">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lin</surname><given-names>CP</given-names></name>
<name><surname>Choi</surname><given-names>YJ</given-names></name>
<name><surname>Hicks</surname><given-names>GG</given-names></name>
<name><surname>He</surname><given-names>L</given-names></name>
</person-group>. <article-title>The emerging functions of the p53-miRNA network in stem cell biology</article-title>. <source>Cell Cycle</source>. <year>2012</year>;<volume>11</volume>:<fpage>2063</fpage>-<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr43-1947601913481355">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>KH</given-names></name>
<name><surname>Li</surname><given-names>M</given-names></name>
<name><surname>Michalowski</surname><given-names>AM</given-names></name>
<etal/></person-group>. <article-title>A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2010</year>;<volume>107</volume>:<fpage>69</fpage>-<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr44-1947601913481355">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sage</surname><given-names>J</given-names></name>
</person-group>. <article-title>The retinoblastoma tumor suppressor and stem cell biology</article-title>. <source>Genes Dev</source>. <year>2012</year>;<volume>26</volume>:<fpage>1409</fpage>-<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr45-1947601913481355">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Copley</surname><given-names>MR</given-names></name>
<name><surname>Beer</surname><given-names>PA</given-names></name>
<name><surname>Eaves</surname><given-names>CJ</given-names></name>
</person-group>. <article-title>Hematopoietic stem cell heterogeneity takes center stage</article-title>. <source>Cell Stem Cell</source>. <year>2012</year>;<volume>10</volume>:<fpage>690</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr46-1947601913481355">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ehninger</surname><given-names>A</given-names></name>
<name><surname>Trumpp</surname><given-names>A</given-names></name>
</person-group>. <article-title>The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in</article-title>. <source>J Exp Med</source>. <year>2011</year>;<volume>208</volume>:<fpage>421</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr47-1947601913481355">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mercier</surname><given-names>FE</given-names></name>
<name><surname>Ragu</surname><given-names>C</given-names></name>
<name><surname>Scadden</surname><given-names>DT</given-names></name>
</person-group>. <article-title>The bone marrow at the crossroads of blood and immunity</article-title>. <source>Nat Rev Immunol</source>. <year>2012</year>;<volume>12</volume>:<fpage>49</fpage>-<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr48-1947601913481355">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>J</given-names></name>
</person-group>. <article-title>Quiescence regulators for hematopoietic stem cell</article-title>. <source>Exp Hematol</source>. <year>2011</year>;<volume>39</volume>:<fpage>511</fpage>-<lpage>20</lpage>.</citation>
</ref>
<ref id="bibr49-1947601913481355">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>L</given-names></name>
<name><surname>Bhatia</surname><given-names>R</given-names></name>
</person-group>. <article-title>Stem cell quiescence</article-title>. <source>Clin Cancer Res</source>. <year>2011</year>;<volume>17</volume>:<fpage>4936</fpage>-<lpage>41</lpage>.</citation>
</ref>
<ref id="bibr50-1947601913481355">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Solar</surname><given-names>GP</given-names></name>
<name><surname>Kerr</surname><given-names>WG</given-names></name>
<name><surname>Zeigler</surname><given-names>FC</given-names></name>
<etal/></person-group>. <article-title>Role of c-mpl in early hematopoiesis</article-title>. <source>Blood</source>. <year>1998</year>;<volume>92</volume>:<fpage>4</fpage>-<lpage>10</lpage>.</citation>
</ref>
<ref id="bibr51-1947601913481355">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yoshihara</surname><given-names>H</given-names></name>
<name><surname>Arai</surname><given-names>F</given-names></name>
<name><surname>Hosokawa</surname><given-names>K</given-names></name>
<etal/></person-group>. <article-title>Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche</article-title>. <source>Cell Stem Cell</source>. <year>2007</year>;<volume>1</volume>:<fpage>685</fpage>-<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr52-1947601913481355">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bersenev</surname><given-names>A</given-names></name>
<name><surname>Wu</surname><given-names>C</given-names></name>
<name><surname>Balcerek</surname><given-names>J</given-names></name>
<name><surname>Tong</surname><given-names>W</given-names></name>
</person-group>. <article-title>Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2</article-title>. <source>J Clin Invest</source>. <year>2008</year>;<volume>118</volume>:<fpage>2832</fpage>-<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr53-1947601913481355">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bersenev</surname><given-names>A</given-names></name>
<name><surname>Wu</surname><given-names>C</given-names></name>
<name><surname>Balcerek</surname><given-names>J</given-names></name>
<etal/></person-group>. <article-title>Lnk constrains myeloproliferative diseases in mice</article-title>. <source>J Clin Invest</source>. <year>2010</year>;<volume>120</volume>:<fpage>2058</fpage>-<lpage>69</lpage>.</citation>
</ref>
<ref id="bibr54-1947601913481355">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arai</surname><given-names>F</given-names></name>
<name><surname>Hirao</surname><given-names>A</given-names></name>
<name><surname>Ohmura</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche</article-title>. <source>Cell</source>. <year>2004</year>;<volume>118</volume>:<fpage>149</fpage>-<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr55-1947601913481355">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maillard</surname><given-names>I</given-names></name>
<name><surname>Koch</surname><given-names>U</given-names></name>
<name><surname>Dumortier</surname><given-names>A</given-names></name>
<etal/></person-group>. <article-title>Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells</article-title>. <source>Cell Stem Cell</source>. <year>2008</year>;<volume>2</volume>:<fpage>356</fpage>-<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr56-1947601913481355">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chiang</surname><given-names>MY</given-names></name>
<name><surname>Shestova</surname><given-names>O</given-names></name>
<name><surname>Xu</surname><given-names>L</given-names></name>
<name><surname>Aster</surname><given-names>JC</given-names></name>
<name><surname>Pear</surname><given-names>WS</given-names></name>
</person-group>. <article-title>Divergent effects of supraphysiological Notch signals on leukemia stem cells and hematopoietic stem cells</article-title>. <source>Blood</source>. <year>2013</year>;<volume>121</volume>:<fpage>905</fpage>-<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr57-1947601913481355">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ding</surname><given-names>L</given-names></name>
<name><surname>Saunders</surname><given-names>TL</given-names></name>
<name><surname>Enikolopov</surname><given-names>G</given-names></name>
<name><surname>Morrison</surname><given-names>SJ</given-names></name>
</person-group>. <article-title>Endothelial and perivascular cells maintain haematopoietic stem cells</article-title>. <source>Nature</source>. <year>2012</year>;<volume>481</volume>:<fpage>457</fpage>-<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr58-1947601913481355">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Winkler</surname><given-names>IG</given-names></name>
<name><surname>Barbier</surname><given-names>V</given-names></name>
<name><surname>Nowlan</surname><given-names>B</given-names></name>
<etal/></person-group>. <article-title>Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance</article-title>. <source>Nat Med</source>. <year>2012</year>;<volume>18</volume>:<fpage>1651</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr59-1947601913481355">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kubota</surname><given-names>Y</given-names></name>
<name><surname>Takubo</surname><given-names>K</given-names></name>
<name><surname>Suda</surname><given-names>T</given-names></name>
</person-group>. <article-title>Bone marrow long label-retaining cells reside in the sinusoidal hypoxic niche</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2008</year>;<volume>366</volume>:<fpage>335</fpage>-<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr60-1947601913481355">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tothova</surname><given-names>Z</given-names></name>
<name><surname>Kollipara</surname><given-names>R</given-names></name>
<name><surname>Huntly</surname><given-names>BJ</given-names></name>
<etal/></person-group>. <article-title>FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress</article-title>. <source>Cell</source>. <year>2007</year>;<volume>128</volume>:<fpage>325</fpage>-<lpage>39</lpage>.</citation>
</ref>
<ref id="bibr61-1947601913481355">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lacorazza</surname><given-names>HD</given-names></name>
<name><surname>Miyazaki</surname><given-names>Y</given-names></name>
<name><surname>Di Cristofano</surname><given-names>A</given-names></name>
<etal/></person-group>. <article-title>The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells</article-title>. <source>Immunity</source>. <year>2002</year>;<volume>17</volume>:<fpage>437</fpage>-<lpage>49</lpage>.</citation>
</ref>
<ref id="bibr62-1947601913481355">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ito</surname><given-names>K</given-names></name>
<name><surname>Hirao</surname><given-names>A</given-names></name>
<name><surname>Arai</surname><given-names>F</given-names></name>
<etal/></person-group>. <article-title>Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells</article-title>. <source>Nat Med</source>. <year>2006</year>;<volume>12</volume>:<fpage>446</fpage>-<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr63-1947601913481355">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Adams</surname><given-names>GB</given-names></name>
<name><surname>Chabner</surname><given-names>KT</given-names></name>
<name><surname>Alley</surname><given-names>IR</given-names></name>
<etal/></person-group>. <article-title>Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor</article-title>. <source>Nature</source>. <year>2006</year>;<volume>439</volume>:<fpage>599</fpage>-<lpage>603</lpage>.</citation>
</ref>
<ref id="bibr64-1947601913481355">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Christopher</surname><given-names>MJ</given-names></name>
<name><surname>Rao</surname><given-names>M</given-names></name>
<name><surname>Liu</surname><given-names>F</given-names></name>
<name><surname>Woloszynek</surname><given-names>JR</given-names></name>
<name><surname>Link</surname><given-names>DC</given-names></name>
</person-group>. <article-title>Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice</article-title>. <source>J Exp Med</source>. <year>2011</year>;<volume>208</volume>:<fpage>251</fpage>-<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr65-1947601913481355">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hock</surname><given-names>H</given-names></name>
<name><surname>Hamblen</surname><given-names>MJ</given-names></name>
<name><surname>Rooke</surname><given-names>HM</given-names></name>
<etal/></person-group>. <article-title>Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells</article-title>. <source>Nature</source>. <year>2004</year>;<volume>431</volume>:<fpage>1002</fpage>-<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr66-1947601913481355">
<label>66.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Khandanpour</surname><given-names>C</given-names></name>
<name><surname>Kosan</surname><given-names>C</given-names></name>
<name><surname>Gaudreau</surname><given-names>MC</given-names></name>
<etal/></person-group>. <article-title>Growth factor independence 1 protects hematopoietic stem cells against apoptosis but also prevents the development of a myeloproliferative-like disease</article-title>. <source>Stem Cells</source>. <year>2011</year>;<volume>29</volume>:<fpage>376</fpage>-<lpage>85</lpage>.</citation>
</ref>
<ref id="bibr67-1947601913481355">
<label>67.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ficara</surname><given-names>F</given-names></name>
<name><surname>Murphy</surname><given-names>MJ</given-names></name>
<name><surname>Lin</surname><given-names>M</given-names></name>
<name><surname>Cleary</surname><given-names>ML</given-names></name>
</person-group>. <article-title>Pbx1 regulates self-renewal of long-term hematopoietic stem cells by maintaining their quiescence</article-title>. <source>Cell Stem Cell</source>. <year>2008</year>;<volume>2</volume>:<fpage>484</fpage>-<lpage>96</lpage>.</citation>
</ref>
<ref id="bibr68-1947601913481355">
<label>68.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Santaguida</surname><given-names>M</given-names></name>
<name><surname>Schepers</surname><given-names>K</given-names></name>
<name><surname>King</surname><given-names>B</given-names></name>
<etal/></person-group>. <article-title>JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal</article-title>. <source>Cancer Cell</source>. <year>2009</year>;<volume>15</volume>:<fpage>341</fpage>-<lpage>52</lpage>.</citation>
</ref>
<ref id="bibr69-1947601913481355">
<label>69.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wilson</surname><given-names>A</given-names></name>
<name><surname>Murphy</surname><given-names>MJ</given-names></name>
<name><surname>Oskarsson</surname><given-names>T</given-names></name>
<etal/></person-group>. <article-title>c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation</article-title>. <source>Genes Dev</source>. <year>2004</year>;<volume>18</volume>:<fpage>2747</fpage>-<lpage>63</lpage>.</citation>
</ref>
<ref id="bibr70-1947601913481355">
<label>70.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reavie</surname><given-names>L</given-names></name>
<name><surname>Della Gatta</surname><given-names>G</given-names></name>
<name><surname>Crusio</surname><given-names>K</given-names></name>
<etal/></person-group>. <article-title>Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase-substrate complex</article-title>. <source>Nat Immunol</source>. <year>2010</year>;<volume>11</volume>:<fpage>207</fpage>-<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr71-1947601913481355">
<label>71.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yuasa</surname><given-names>H</given-names></name>
<name><surname>Oike</surname><given-names>Y</given-names></name>
<name><surname>Iwama</surname><given-names>A</given-names></name>
<etal/></person-group>. <article-title>Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression</article-title>. <source>EMBO J</source>. <year>2005</year>;<volume>24</volume>:<fpage>1976</fpage>-<lpage>87</lpage>.</citation>
</ref>
<ref id="bibr72-1947601913481355">
<label>72.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lessard</surname><given-names>J</given-names></name>
<name><surname>Sauvageau</surname><given-names>G</given-names></name>
</person-group>. <article-title>Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells</article-title>. <source>Nature</source>. <year>2003</year>;<volume>423</volume>:<fpage>255</fpage>-<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr73-1947601913481355">
<label>73.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Oguro</surname><given-names>H</given-names></name>
<name><surname>Iwama</surname><given-names>A</given-names></name>
<name><surname>Morita</surname><given-names>Y</given-names></name>
<name><surname>Kamijo</surname><given-names>T</given-names></name>
<name><surname>van Lohuizen</surname><given-names>M</given-names></name>
<name><surname>Nakauchi</surname><given-names>H</given-names></name>
</person-group>. <article-title>Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice</article-title>. <source>J Exp Med</source>. <year>2006</year>;<volume>203</volume>:<fpage>2247</fpage>-<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr74-1947601913481355">
<label>74.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Oguro</surname><given-names>H</given-names></name>
<name><surname>Yuan</surname><given-names>J</given-names></name>
<name><surname>Ichikawa</surname><given-names>H</given-names></name>
<etal/></person-group>. <article-title>Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the Polycomb protein Bmi1</article-title>. <source>Cell Stem Cell</source>. <year>2010</year>;<volume>6</volume>:<fpage>279</fpage>-<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr75-1947601913481355">
<label>75.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>T</given-names></name>
<name><surname>Rodrigues</surname><given-names>N</given-names></name>
<name><surname>Shen</surname><given-names>H</given-names></name>
<etal/></person-group>. <article-title>Hematopoietic stem cell quiescence maintained by p21cip1/waf1</article-title>. <source>Science</source>. <year>2000</year>;<volume>287</volume>:<fpage>1804</fpage>-<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr76-1947601913481355">
<label>76.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van Os</surname><given-names>R</given-names></name>
<name><surname>Kamminga</surname><given-names>LM</given-names></name>
<name><surname>Ausema</surname><given-names>A</given-names></name>
<etal/></person-group>. <article-title>A Limited role for p21Cip1/Waf1 in maintaining normal hematopoietic stem cell functioning</article-title>. <source>Stem Cells</source>. <year>2007</year>;<volume>25</volume>:<fpage>836</fpage>-<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr77-1947601913481355">
<label>77.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tesio</surname><given-names>M</given-names></name>
<name><surname>Trumpp</surname><given-names>A</given-names></name>
</person-group>. <article-title>Breaking the cell cycle of HSCs by p57 and friends</article-title>. <source>Cell Stem Cell</source>. <year>2011</year>;<volume>9</volume>:<fpage>187</fpage>-<lpage>92</lpage>.</citation>
</ref>
<ref id="bibr78-1947601913481355">
<label>78.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Matsumoto</surname><given-names>A</given-names></name>
<name><surname>Takeishi</surname><given-names>S</given-names></name>
<name><surname>Kanie</surname><given-names>T</given-names></name>
<etal/></person-group>. <article-title>p57 is required for quiescence and maintenance of adult hematopoietic stem cells</article-title>. <source>Cell Stem Cell</source>. <year>2011</year>;<volume>9</volume>:<fpage>262</fpage>-<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr79-1947601913481355">
<label>79.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zou</surname><given-names>P</given-names></name>
<name><surname>Yoshihara</surname><given-names>H</given-names></name>
<name><surname>Hosokawa</surname><given-names>K</given-names></name>
<etal/></person-group>. <article-title>p57(Kip2) and p27(Kip1) cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70</article-title>. <source>Cell Stem Cell</source>. <year>2011</year>;<volume>9</volume>:<fpage>247</fpage>-<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr80-1947601913481355">
<label>80.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Janzen</surname><given-names>V</given-names></name>
<name><surname>Forkert</surname><given-names>R</given-names></name>
<name><surname>Fleming</surname><given-names>HE</given-names></name>
<etal/></person-group>. <article-title>Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a</article-title>. <source>Nature</source>. <year>2006</year>;<volume>443</volume>:<fpage>421</fpage>-<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr81-1947601913481355">
<label>81.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yuan</surname><given-names>Y</given-names></name>
<name><surname>Shen</surname><given-names>H</given-names></name>
<name><surname>Franklin</surname><given-names>DS</given-names></name>
<name><surname>Scadden</surname><given-names>DT</given-names></name>
<name><surname>Cheng</surname><given-names>T</given-names></name>
</person-group>. <article-title>In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C</article-title>. <source>Nat Cell Biol</source>. <year>2004</year>;<volume>6</volume>:<fpage>436</fpage>-<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr82-1947601913481355">
<label>82.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Walkley</surname><given-names>CR</given-names></name>
<name><surname>Shea</surname><given-names>JM</given-names></name>
<name><surname>Sims</surname><given-names>NA</given-names></name>
<name><surname>Purton</surname><given-names>LE</given-names></name>
<name><surname>Orkin</surname><given-names>SH</given-names></name>
</person-group>. <article-title>Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment</article-title>. <source>Cell</source>. <year>2007</year>;<volume>129</volume>:<fpage>1081</fpage>-<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr83-1947601913481355">
<label>83.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Viatour</surname><given-names>P</given-names></name>
<name><surname>Somervaille</surname><given-names>TC</given-names></name>
<name><surname>Venkatasubrahmanyam</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family</article-title>. <source>Cell Stem Cell</source>. <year>2008</year>;<volume>3</volume>:<fpage>416</fpage>-<lpage>28</lpage>.</citation>
</ref>
<ref id="bibr84-1947601913481355">
<label>84.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fukushima</surname><given-names>K</given-names></name>
<name><surname>Matsumura</surname><given-names>I</given-names></name>
<name><surname>Ezoe</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>FIP1L1-PDGFRalpha imposes eosinophil lineage commitment on hematopoietic stem/progenitor cells</article-title>. <source>J Biol Chem</source>. <year>2009</year>;<volume>284</volume>:<fpage>7719</fpage>-<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr85-1947601913481355">
<label>85.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Y</given-names></name>
<name><surname>Elf</surname><given-names>SE</given-names></name>
<name><surname>Miyata</surname><given-names>Y</given-names></name>
<etal/></person-group>. <article-title>p53 regulates hematopoietic stem cell quiescence</article-title>. <source>Cell Stem Cell</source>. <year>2009</year>;<volume>4</volume>:<fpage>37</fpage>-<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr86-1947601913481355">
<label>86.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wachsman</surname><given-names>G</given-names></name>
<name><surname>Heidstra</surname><given-names>R</given-names></name>
<name><surname>Scheres</surname><given-names>B</given-names></name>
</person-group>. <article-title>Distinct cell-autonomous functions of RETINOBLASTOMA-RELATED in Arabidopsis stem cells revealed by the Brother of Brainbow clonal analysis system</article-title>. <source>Plant Cell</source>. <year>2011</year>;<volume>23</volume>:<fpage>2581</fpage>-<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr87-1947601913481355">
<label>87.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>He</surname><given-names>S</given-names></name>
<name><surname>Nakada</surname><given-names>D</given-names></name>
<name><surname>Morrison</surname><given-names>SJ</given-names></name>
</person-group>. <article-title>Mechanisms of stem cell self-renewal</article-title>. <source>Annu Rev Cell Dev Biol</source>. <year>2009</year>;<volume>25</volume>:<fpage>377</fpage>-<lpage>406</lpage>.</citation>
</ref>
<ref id="bibr88-1947601913481355">
<label>88.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Viatour</surname><given-names>P</given-names></name>
<name><surname>Ehmer</surname><given-names>U</given-names></name>
<name><surname>Saddic</surname><given-names>LA</given-names></name>
<etal/></person-group>. <article-title>Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway</article-title>. <source>J Exp Med</source>. <year>2011</year>;<volume>208</volume>:<fpage>1963</fpage>-<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr89-1947601913481355">
<label>89.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pajcini</surname><given-names>KV</given-names></name>
<name><surname>Corbel</surname><given-names>SY</given-names></name>
<name><surname>Sage</surname><given-names>J</given-names></name>
<name><surname>Pomerantz</surname><given-names>JH</given-names></name>
<name><surname>Blau</surname><given-names>HM</given-names></name>
</person-group>. <article-title>Transient inactivation of Rb and ARF yields regenerative cells from postmitotic mammalian muscle</article-title>. <source>Cell Stem Cell</source>. <year>2010</year>;<volume>7</volume>:<fpage>198</fpage>-<lpage>213</lpage>.</citation>
</ref>
<ref id="bibr90-1947601913481355">
<label>90.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hong</surname><given-names>H</given-names></name>
<name><surname>Takahashi</surname><given-names>K</given-names></name>
<name><surname>Ichisaka</surname><given-names>T</given-names></name>
<etal/></person-group>. <article-title>Suppression of induced pluripotent stem cell generation by the p53-p21 pathway</article-title>. <source>Nature</source>. <year>2009</year>;<volume>460</volume>:<fpage>1132</fpage>-<lpage>5</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>